MMærsk Read More Maersk Finds Profit in the Traffic Jam2026-08-13 Maersk Finds Profit in the Traffic Jam – Moby THE GIST Our analysts just identified a stock with…
NNovo Nordisk Read More Novo Nordisk tumbles as Wegovy sales miss, trial setback overshadow raised outlook2026-08-07 Investing.com — Novo Nordisk (CSE:NOVOb) (NYSE:NVO) hiked its full-year guidance, saying annual sales and operating profit should decline…
NNovo Nordisk Read More Novo Nordisk Stock Falls 4% Despite Stronger GLP-1 Outlook2026-08-06 This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO), the Danish pharmaceutical giant behind Wegovy and Ozempic, raised…
NNovo Nordisk Read More Novo Nordisk Swallows the Bitter Pill2026-08-05 Novo Nordisk Swallows the Bitter Pill – Moby THE GIST Our analysts just identified a stock with the…
NNovo Nordisk Read More Novo Nordisk Stock Falls 4% Despite Stronger GLP-1 Outlook2026-08-05 This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO), the Danish pharmaceutical giant behind Wegovy and Ozempic, raised…
NNovo Nordisk Read More Novo Nordisk raises adjusted sales and adjusted operating profit outlook for 20262026-08-05 Novo Nordisk A/S Bagsværd, Denmark, 4 August 2026 – Novo Nordisk today announced adjusted sales and adjusted operating profit…
NNovo Nordisk Read More Novo Nordisk reports adjusted operating profit of DKK 33,389 million for Q2 2026 and raises full-year outlook2026-08-04 Novo Nordisk A/S Bagsværd, 4 August 2026 – Financial report for the period 1 January 2026 to 30…
NNovo Nordisk Read More Novo Nordisk Q1 2026 earnings beat on Wegovy pill demand2026-05-11 Novo Nordisk raised its full-year guidance on Wednesday after first-quarter sales of its Wegovy weight loss pill came…
NNovo Nordisk Read More Novo Nordisk’s adjusted operating profit reached DKK 32,858 million in Q1 20262026-05-09 Novo Nordisk A/S Bagsværd, Denmark, 6 May 2026 – Financial report for the period 1 January 2026 to…
NNovo Nordisk Read More Novo Nordisk beats estimates, raises guidance on Wegovy pill surge2026-05-08 Novo Nordisk beats estimates, raises guidance on Wegovy pill surge Proactive uses images sourced from Shutterstock Novo Nordisk…
NNovo Nordisk Read More Novo Nordisk slightly raises outlook as first-quarter profit beats forecast2026-05-07 COPENHAGEN, May 6 (Reuters) – Novo Nordisk, the maker of weight-loss drug Wegovy, on Wednesday reported first-quarter revenue…
NNovo Nordisk Read More Novo Nordisk (NVO) lifts 2026 outlook as obesity drug demand remains strong2026-05-06 Wegovy ©Novo Nordisk Novo Nordisk (NYSE:NVO) raised its full-year guidance on Wednesday, citing continued strong demand for its…